Krystal Biotech Inc (KRYS)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

2100 WHARTON STREET PITTSBURGH, PA 15203

Krystal Biotech, Inc. operates as a biopharmaceutical company. The Company develops a proprietary gene therapy platform for the patients suffering from rare debilitating disorders. Krystal Biotech serves patients in the State of Pennsylvania.

Data based on most recent fiscal year report
Market Cap941.837 Million Shares Outstanding17.31 Million Avg Volume196.139 Thousand
1-Yr BETA vs S&P TR1.006 Current Ratio43.33 Quick Ratio43.33
View SEC Filings from KRYS instead.

View recent insider trading info

Funds Holding KRYS (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding KRYS BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

50 Thousand total shares from 14 transactions

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

KRISHNAN SUMA CHIEF OPERATING OFFICER

  • Officer
  • Director
  • 10% Owner
4,050,086 2019-12-16 1

RILEY ANTONY A CHIEF FINANCIAL OFFICER

  • Officer
9,050 2019-11-19 3

KRISHNAN KRISH S PRESIDENT AND CEO

  • Officer
  • Director
  • 10% Owner
4,100,086 2019-11-15 1

JANNEY DANIEL

  • Director
366,362 2019-08-29 1

GANGOLLI JULIAN S PRESIDENT, NORTH AMERICA

  • Officer
106,548 2019-05-10 2

NORBY R DOUGLAS

  • Director
0 2018-05-31 0

ROSSI DINO A

  • Director
0 2018-05-31 0

SUN PHARMA (NETHERLANDS) B.V.

  • 10% Owner
0 2017-09-19 0

GANORKAR KIRTI

  • Director
0 2017-09-19 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

KRISHNAN SUMA - Director - Officer - > 10% Owner CHIEF OPERATING OFFICER

2019-12-18 S 900 $61.28 d 1,957,457 4,050,086.00 direct yes

KRISHNAN SUMA - Director - Officer - > 10% Owner CHIEF OPERATING OFFICER

2019-12-18 S 239 $63.31 d 1,951,462 4,050,086.00 direct yes

KRISHNAN SUMA - Director - Officer - > 10% Owner CHIEF OPERATING OFFICER

2019-12-18 S 1,017 $60.19 d 1,958,357 4,050,086.00 direct yes

KRISHNAN SUMA - Director - Officer - > 10% Owner CHIEF OPERATING OFFICER

2019-12-18 S 5,756 $62.65 d 1,951,701 4,050,086.00 direct yes

KRISHNAN SUMA - Director - Officer - > 10% Owner CHIEF OPERATING OFFICER

2019-12-18 S 1,200 $59.49 d 1,959,374 4,050,086.00 direct yes

KRISHNAN SUMA - Director - Officer - > 10% Owner CHIEF OPERATING OFFICER

2019-12-17 S 279 $63.35 d 1,960,574 4,050,086.00 direct yes

KRISHNAN SUMA - Director - Officer - > 10% Owner CHIEF OPERATING OFFICER

2019-12-17 S 8,799 $60.46 d 1,963,578 4,050,086.00 direct yes

KRISHNAN SUMA - Director - Officer - > 10% Owner CHIEF OPERATING OFFICER

2019-12-17 S 1,834 $62.79 d 1,960,853 4,050,086.00 direct yes

KRISHNAN SUMA - Director - Officer - > 10% Owner CHIEF OPERATING OFFICER

2019-12-17 S 8,138 $59.87 d 1,972,377 4,050,086.00 direct yes

KRISHNAN SUMA - Director - Officer - > 10% Owner CHIEF OPERATING OFFICER

2019-12-17 S 891 $61.72 d 1,962,687 4,050,086.00 direct yes

KRISHNAN SUMA - Director - Officer - > 10% Owner CHIEF OPERATING OFFICER

2019-12-16 S 7,373 $62.84 d 1,994,089 4,050,086.00 direct yes

KRISHNAN SUMA - Director - Officer - > 10% Owner CHIEF OPERATING OFFICER

2019-12-16 S 5,856 $64.28 d 1,980,837 4,050,086.00 direct yes

KRISHNAN SUMA - Director - Officer - > 10% Owner CHIEF OPERATING OFFICER

2019-12-16 S 7,396 $63.62 d 1,986,693 4,050,086.00 direct yes

KRISHNAN SUMA - Director - Officer - > 10% Owner CHIEF OPERATING OFFICER

2019-12-16 S 322 $65.60 d 1,980,515 4,050,086.00 direct yes
Click here to report any possible errors with this stock listing.

Elevate your investments